Cargando…

Multiparametric MRI-based differentiation of WHO grade II/III glioma and WHO grade IV glioblastoma

Non-invasive, imaging-based examination of glioma biology has received increasing attention in the past couple of years. To this end, the development and refinement of novel MRI techniques, reflecting underlying oncogenic processes such as hypoxia or angiogenesis, has greatly benefitted this researc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiestler, Benedikt, Kluge, Anne, Lukas, Mathias, Gempt, Jens, Ringel, Florian, Schlegel, Jürgen, Meyer, Bernhard, Zimmer, Claus, Förster, Stefan, Pyka, Thomas, Preibisch, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064384/ https://www.ncbi.nlm.nih.gov/pubmed/27739434 http://dx.doi.org/10.1038/srep35142

Ejemplares similares

Diffusion tensor image features predict IDH genotype in newly diagnosed WHO grade II/III gliomas
por: Eichinger, Paul, et al.
Publicado: (2017)

The wavelet power spectrum of perfusion weighted MRI correlates with tumor vascularity in biopsy-proven glioblastoma samples
por: Rotkopf, Lukas T., et al.
Publicado: (2020)

Assessment of the Extent of Resection in Surgery of High-Grade Glioma—Evaluation of Black Blood Sequences for Intraoperative Magnetic Resonance Imaging at 3 Tesla
por: Finck, Tom, et al.
Publicado: (2020)

Multiparametric Characterization of Intracranial Gliomas Using Dynamic [18F]FET-PET and Magnetic Resonance Spectroscopy
por: Pyka, Thomas, et al.
Publicado: (2022)

Visualizing cellularity and angiogenesis in newly-diagnosed glioblastoma with diffusion and perfusion MRI and FET-PET imaging
por: Liesche-Starnecker, Friederike, et al.
Publicado: (2021)

Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma
por: Buchwald, Zachary S., et al.
Publicado: (2020)

Subtyping of gliomas of various WHO grades by the application of immunohistochemistry
por: Popova, Svetlana N, et al.
Publicado: (2014)

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

Tracking the Corticospinal Tract in Patients With High-Grade Glioma: Clinical Evaluation of Multi-Level Fiber Tracking and Comparison to Conventional Deterministic Approaches
por: Zhylka, Andrey, et al.
Publicado: (2021)

Imaging the WHO 2021 Brain Tumor Classification: Fully Automated Analysis of Imaging Features of Newly Diagnosed Gliomas
por: Griessmair, Michael, et al.
Publicado: (2023)

Progressive disease in glioblastoma: Benefits and limitations of semi-automated volumetry
por: Huber, Thomas, et al.
Publicado: (2017)

Feasibility of evaluating the histologic and genetic subtypes of WHO grade II-IV gliomas by diffusion-weighted imaging
por: Liu, Sirui, et al.
Publicado: (2022)

Fully automated analysis combining [(18)F]-FET-PET and multiparametric MRI including DSC perfusion and APTw imaging: a promising tool for objective evaluation of glioma progression
por: Paprottka, K. J., et al.
Publicado: (2021)

Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas
por: Schön, S., et al.
Publicado: (2020)

Multiparametric Magnetic Resonance Imaging Correlates of Isocitrate Dehydrogenase Mutation in WHO high-Grade Astrocytomas
por: Sahu, Arpita, et al.
Publicado: (2022)

MR imaging by 3D T1-weighted black blood sequences may improve delineation of therapy-naive high-grade gliomas
por: Finck, Tom, et al.
Publicado: (2020)

Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas
por: Tsai, Wen-Chiuan, et al.
Publicado: (2016)

Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas
por: Bernhardt, Denise, et al.
Publicado: (2020)

Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas
por: Weber, Lorenz, et al.
Publicado: (2022)

WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial
por: Varlet, Pascale, et al.
Publicado: (2020)

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm
por: Escalante Abril, Paola A., et al.
Publicado: (2015)

Machine Learning Models for Multiparametric Glioma Grading With Quantitative Result Interpretations
por: Wang, Xiuying, et al.
Publicado: (2019)

Infarct volume after glioblastoma surgery as an independent prognostic factor
por: Bette, Stefanie, et al.
Publicado: (2016)

PROX1 is a predictor of survival for gliomas WHO grade II
por: Elsir, T, et al.
Publicado: (2011)

Angiocentric glioma, a recently added WHO grade-I tumor
por: Kumar, Manoj, et al.
Publicado: (2015)

CD34 Over-Expression is Associated With Gliomas’ Higher WHO Grade
por: Kong, Xiangyi, et al.
Publicado: (2016)

T2 mapping of molecular subtypes of WHO grade II/III gliomas
por: Kern, Maike, et al.
Publicado: (2020)

Erratum: WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm
por: Abril, Paola A. Escalante, et al.
Publicado: (2015)

Multiparametrical diffusion weighted imaging for the detection of anaplastic transformation of low-grade gliomas
por: Freitag, MT, et al.
Publicado: (2014)

A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy
por: Steidl, Eike, et al.
Publicado: (2021)

The presence of TIM‐3 positive cells in WHO grade III and IV astrocytic gliomas correlates with isocitrate dehydrogenase mutation status
por: Sørensen, Mia D., et al.
Publicado: (2021)

Human Glioma Migration and Infiltration Properties as a Target for Personalized Radiation Medicine
por: Wank, Michaela, et al.
Publicado: (2018)

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas
por: Chang, Yu-Zhou, et al.
Publicado: (2020)

The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II
por: Smits, Anja, et al.
Publicado: (2011)

A Probabilistic Atlas of Diffuse WHO Grade II Glioma Locations in the Brain
por: Parisot, Sarah, et al.
Publicado: (2016)

Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II
por: Karschnia, Philipp, et al.
Publicado: (2020)

A Model for Predicting Clinical Prognosis in Patients with WHO Grade 2 Glioma
por: Gao, Qi, et al.
Publicado: (2022)

Facing Contrast-Enhancing Gliomas: Perfusion MRI in Grade III and Grade IV Gliomas according to Tumor Area
por: Di Stefano, Anna Luisa, et al.
Publicado: (2014)

Risk factors for neurocognitive impairment in patients with benign intracranial lesions
por: Bette, Stefanie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_07d1s9tpbjoibusnkksiui99ag